1Y Close · As of Aug 26, 2026
NATURECELL operates in the Pharmaceuticals sector.
Legal name: NATURECELL CO.,LTD.
In fiscal year 2025, NATURECELL (007390) reported revenue of 20.7 billion KRW, down 35.9% from 32.3 billion KRW a year earlier.
Operating profit was -3.6 billion KRW and net income was -2.8 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 1.58 trillion KRW, with a P/B of 25.00.
These figures can be verified in the DART filing (receipt no. 20260323001523).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 20.7B | -3.6B | -2.8B |
| 2024 | 32.3B | 598M | 1.2B |
| 2023 | 19.4B | -10.3B | -11.7B |
Recent Filings
Acquisition of Other Shares
Capital Increase Decision (Subsidiary Material Matters)
Semi-Annual Report (2026.06)
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Treasury Stock: No treasury stock filings.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-26 | Acquisition of Other Shares |
| 2026-08-26 | Capital Increase Decision (Subsidiary Material Matters) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-07 | Securities Issuance Result (Voluntary Disclosure) |
| 2026-08-03 | Stock Option Grant Report |